tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Cash flow

Compare
216 Followers

Atea Pharmaceuticals Cash Flow

AVIR's free cash flow for Q4 2024 was $-30.40M. For the 2024 fiscal year, AVIR's free cash flow was decreased by $-50.10M and operating cash flow was $-30.40M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -135.50M$ -85.39M$ -120.98M$ -87.00M$ 296.73M
Investing Cash Flow
$ 56.10M$ 40.30M$ -455.41M$ -4.00K$ -26.00K
Financing Cash Flow
$ 267.00K$ 257.00K$ 370.00K$ 1.47M$ 531.75M
End Cash Position
$ 64.70M$ 143.82M$ 188.66M$ 764.68M$ 850.22M
Free Cash Flow
$ -135.50M$ -85.39M$ -122.92M$ -87.01M$ 296.71M
Currency in USD

Atea Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis